Positive Kappa-Deleting Recombination Excision Circles (KREC) Newborn Screening in a Neonate With Intrauterine Exposure to Rituximab

Scand J Immunol. 2018 Jan;87(1):54-56. doi: 10.1111/sji.12627.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Agammaglobulinemia / diagnosis*
  • Agammaglobulinemia / etiology
  • Agammaglobulinemia / genetics
  • Antigens, CD20 / metabolism
  • B-Lymphocytes / pathology*
  • Diagnostic Errors / prevention & control
  • Drug-Related Side Effects and Adverse Reactions / diagnosis*
  • Female
  • Fetomaternal Transfusion
  • HIV Infections / diagnosis*
  • HIV Infections / drug therapy
  • HIV Infections / genetics
  • HIV-1 / immunology*
  • Humans
  • Immunity, Maternally-Acquired*
  • Immunoglobulin kappa-Chains / genetics*
  • Immunosuppression Therapy / adverse effects
  • Infant
  • Infant, Newborn
  • Lymphocyte Depletion
  • Lymphopenia
  • Male
  • Maternal Exposure / adverse effects
  • Neonatal Screening / methods
  • Pregnancy
  • Recombination, Genetic
  • Rituximab / adverse effects
  • Rituximab / therapeutic use*

Substances

  • Antigens, CD20
  • Immunoglobulin kappa-Chains
  • Rituximab